Internal Medicine, Medical Oncology · Milford, MA
NPI
1053791707
Since 2015
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
20 Prospect St
Milford, MA, 01757
Phone (508) 488-3700
Groups this clinician bills Medicare through
Medicare paid, 2024
$81K
1,336 services
Medicare patients, 2024
223
Average age 77
Drug cost, 2024
$5.8M
1,219 prescriptions
Company payments, 2025
$21.72
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel Fein was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 498 times for 147 patients. In total Daniel Fein billed 1,336 services in 17 codes, and Medicare paid $81K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-20.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 498 | 147 | $13.43 | $6,690 |
| 99215 Office E&M - Established | Facility | 334 | 93 | $111.71 | $37K |
| 99214 Office E&M - Established | Facility | 190 | 104 | $72.83 | $14K |
| 99232 Hospital E&M - Subsequent | Facility | 60 | 27 | $61.93 | $3,716 |
| 99233 Hospital E&M - Subsequent | Facility | 48 | 23 | $94.87 | $4,554 |
| 99213 Office E&M - Established | Facility | 37 | 32 | $45.89 | $1,698 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 35 | 29 | $13.41 | $469 |
| 99443 Telephone Services | Office | 21 | 13 | $102.48 | $2,152 |
| 99205 Office E&M - New | Facility | 18 | 18 | $151.78 | $2,732 |
| 99214 Office E&M - Established | Office | 16 | 13 | $101.88 | $1,630 |
| 99213 Office E&M - Established | Office | 15 | 12 | $73.86 | $1,108 |
By year: 2022 $49K for 529 services; 2023 $73K for 819 services; 2024 $81K for 1,336 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel Fein prescribed most often to Medicare patients was Orgovyx (Relugolix), with 239 prescriptions and refills. In total Daniel Fein wrote 1,219 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Orgovyx Relugolix | 239 | 245 | 35 | $636K |
| Nubeqa Darolutamide | 216 | 216 | 27 | $2.6M |
| Abiraterone Acetate Generic | 156 | 172 | 23 | $257K |
| Xtandi Enzalutamide | 145 | 145 | 21 | $1.8M |
| Prednisone Generic | 98 | 181 | 25 | $462 |
| Dexamethasone Generic | 44 | 44 | 13 | $370 |
| Tamsulosin Hcl Generic | 23 | 69 | Under 11 | $639 |
| Gabapentin Generic | 15 | 15 | Under 11 | $91.02 |
| Talzenna Talazoparib Tosylate | 15 | 15 | Under 11 | $222K |
| Oxycodone Hcl Generic | 14 | 14 | Under 11 | $72.32 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 13 | 20 | Under 11 | $93.55 |
| Metformin Hcl Generic | 12 | 32 | Under 11 | $111 |
| Famotidine Generic | 12 | 36 | Under 11 | $171 |
| Bicalutamide Generic | 12 | 32 | Under 11 | $374 |
| Balversa Erdafitinib | 11 | 11 | Under 11 | $221K |
Brand drugs: 661 claims; generic drugs: 558 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel Fein $21.72 ($21.72 in general payments such as food, travel and fees) from 1 company. The largest payer was Astellas Pharma US Inc with $21.72.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 1 | $21.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.